Febuxostat
Febuxostat is a prescription medication used to treat gout by reducing uric acid levels in the body. It works as a xanthine oxidase inhibitor. Available in 40 mg and 80 mg oral tablets, manufactured by Tris Pharma Inc. under ANDA210292. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Febuxostat is a prescription medication used to treat gout by reducing uric acid levels in the body. It works as a xanthine oxidase inhibitor. Available in 40 mg and 80 mg oral tablets, manufactured by Tris Pharma Inc. under ANDA210292. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Febuxostat",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Febuxostat — ANDA 206266 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206266"
}
]
|
| identifier | ANDA206266 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-manufacturers",
"pharmaceuticals",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Febuxostat |
